125I-epsilon-toxin showed high affinity to rat brain homogenates and synaptosomal membrane fractions, having single binding phases with dissociation constants (Kds) of 2.5 and 3.3 nM, respectively. Treatment of synaptosomal membrane fractions with pronase and neuraminidase lowered the binding of the labeled toxin, whereas treatment with trypsin and phospholipase C did not. Heating of the fractions resulted in a decrease in the binding of the toxin. These data suggest that interaction of epsilon-toxin with cell membranes in the brain is facilitated by a sialoglycoprotein. On the other hand, treatment of the membrane fractions with lipase resulted in complete loss of binding, suggesting that the interaction may require an appropriate lipid environment. These data suggest the presence of specific binding sites in brain tissue for epsilon-toxin.
Epsilon-toxin produced by Clostridiumperfringens type D is thought to be closely correlated with enterotoxemia of sheep (2, 3, 13) . The toxin has been reported to increase vascular permeability in the brain (7) . The major pathological changes caused by enterotoxemia appear to occur in the brain, as reported by Hartley (9) and Griner and Carlson (8) . We have reported that the toxin is specifically accumulated in the brain of mice after intravenous injection of the toxin (14) . Furthermore, we have reported that lethal and pressor activities of epsilon-toxin in mice and rats, respectively (17) , and contractile responses of rat-isolated ileum to the toxin (23) were significantly prevented by pretreatment with epsilon-toxin inactivated by modification of carboxyl groups, amino groups, or histidine residues with various agents (15) . In the present work, the binding of the toxin to brain tissue of rats and the effects of agent-inactivated epsilon-toxins and presynaptic neurotoxins on the binding of epsilon-toxin to synaptosomal membrane fractions were investigated.
Epsilon-prototoxin and -toxin were purified by chromatographic techniques from a fluid culture of C. perfringens type D (NCTC 8346) as previously described (22) . The toxin was inactivated by treatment with 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) in the presence of glycine methyl ester (20) , 2,4,6-trinitrobenzenesulfonic acid (TNBS) (19) , succinic anhydride (SA) (19) , tetranitromethane (TNM) (21) , N-acetylimidazole (NAI) (21) , or N-bromosuccinimide (NBS) (17, 18) as described previously. Protein estimations were determined by the method of Lowry et al. (12) by using bovine serum albumin (BSA) as a standard.
Brain homogenates were prepared from rat brains as follows. The brains were collected in ice-cold 0.01 M phosphate buffer (pH 7.0) containing 0.9% NaCl. Homogenization was carried out in a Teflon-glass apparatus at 4°C. After centrifugation (10,000 x g, 15 min) of the homogenates, the pellets were rehomogenized and centrifuged at 1,000 x g for 5 min to remove large debris. The supernatant was centrifuged again (10,000 x g, 15 min), and the resulting pellet was centrifuged in the same way three more times and finally resuspended in a small volume of 0.01 M phosphate buffer (pH 7.0). Synaptosomal membrane fractions from whole rat * Corresponding author. brain were prepared by the method of Cotman (5) . 1251_ labeled epsilon-toxin was prepared according to the method of Bolton and Hunter as described previously (1, 14) . The labeled toxin retained at least 80% of the lethal activity of the intact toxin.
Properties of 125I-labeled epsilon-toxin binding to rat brain homogenates and synaptosomal membrane fractions were investigated (Fig. 1) . When 125I-epsilon-toxin was incubated with the homogenates or the membrane fractions, the bound radioactivity was proportional to the amount of 125I-epsilontoxin, and the amount of radioactivity bound to the membrane fractions was about three times more than that bound to the brain homogenates. The (Fig. 1B) .
To clarify the chemical nature of the toxin receptor(s), the synaptosomal membrane fractions were pretreated with hydrolytic enzymes and subsequently assayed for toxin binding (Table 1) . Membrane fractions (12.5 pLg) in 500 ml of 20 mM Tris-HCl buffer (pH 7.5) containing 5 mM CaCl2 were treated with various concentrations of trypsin (porcine pancreas; Sigma), pronase (Streptomyces griseus; Sigma), or neuraminidase (C. perfringens; Sigma) at 37'C for 30 min. Synaptosomal membrane fractions (12.5 ,ug) were treated with phospholipase C purified by the method of Fujii et al. (6) in 500 ml of 20 mM Tris-HCl buffer (pH 7.5) containing 0.9% NaCl and 20 mM CaCl2 for 30 min or with lipase (porcine pancreas; Sigma) in 500 ml of 10 mM phosphate buffer (pH 8.0) at 37°C for 30 min. After incubation, the membrane fractions were washed twice with 20 mM TrisHCl buffer (pH 7.5) containing 0.5% BSA and resuspended in 500 ml of the buffer.
At concentrations as high as 100 ,ug/ml, trypsin and phospholipase C failed to alter toxin binding. Pronase reduced specific binding by 60% at 60 ,ug/ml. Neuraminidase also lowered binding by 80 and 51% at 40 and 80 ,ug/ml, respectively. On the other hand, treatment of the toxin with 10 ,000 x g for 5 min. The pellets were washed twice with 3 ml of the incubation buffer (4°C) and were centrifuged again. After aspiration of the supernatant, the radioactivity bound to the pellets was measured as described previously (14) . To determine the level of specific binding, the homogenates and the membrane fractions were preincubated with unlabeled epsilon-toxin for 30 min prior to the addition of the labeled toxin. The insets show the data recalculated to fit a Scatchard plot, according to the method of Klotz and Hunston (11) . B/F, bound toxin/free toxin.
proteolytic enzymes under these conditions resulted in no effect on the lethal activity of the toxin and no change of mobility on sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Lipase decreased binding in a dose-dependent manner to about 5% of that of the control at 64 U/ml. Binding of the toxin to heated membrane fractions was investigated. Heating at 60°C for 10 min resulted in no effect on toxin binding, heating at 70°C caused about a 50% decrease in binding, and heating at 80°C resulted in a complete loss of binding.
Binding of '25I-epsilon-toxin to the membrane fractions preincubated with various amounts of epsilon-toxin inactivated by various agents was investigated. As shown in Fig.  2 , TNBS-, EDC-, and SA-inactivated toxins inhibited binding of the labeled toxin to the fractions in a dose-dependent manner, but SA-inactivated toxin did not do so strongly. From these data, the inhibitory concentrations which reduced the binding of the labeled toxin to 50% of control Fig. 2, 260 pmol of NBS-, NAI-, or TNM-inactivated toxin did not inhibit the binding of the labeled toxin. We have reported that epsilon-toxin causes the release of acetylcholine from cholinergic nerve endings (23) . The effect of presynaptic neurotoxins such as ,-bungarotoxin or botulinum toxin on the binding of epsilon-toxin to the fractions was investigated (Fig. 3) . ,-Bungarotoxin blocked the binding of epsilon-toxin to the fractions in a dose-dependent manner, and maximal inhibition was approximately 60% of that of the control under the same conditions. The IC50 of 1-bungarotoxin was estimated to be approximately 185 pmol. On the other hand, the IC50 of prototoxin was approximately 8 pmol, showing that the binding of prototoxin is approximately 24-fold higher than that of 3-bungarotoxin. Botulinum toxin did not inhibit binding.
Buxton (4) and Worthington et al. (26) have reported that prior administration of formalinized epsilon-toxin inhibited both the increase in vascular permeability caused by the toxin in the brain and the lethal activity of the toxin. We have reported that lethal activity, pressor activity, and contractile responses of rat-isolated ileum to the toxin are prevented by pretreatment with TNBS-, EDC-, SA-, or ethoxyformic anhydride-inactivated toxin but not by pretreatment with NBS-, NAI-, or TNM-inactivated toxin (15) . In the present work, TNBS-, EDC-, and SA-inactivated toxins inhibited binding of the labeled toxin to the membrane fractions of rat brain in a dose-dependent manner, but NBS-, NAI-, and TNM-inactivated toxins did not, indicating that the inhibitory effect of these inactivated toxins on biological activities caused by epsilon-toxin is the same as the effect of these inactivated toxins on the binding of epsilon-toxin to the fractions. We have reported that the pretreatment with (12.5 ,ug) were incubated with inactivated epsilon-toxins in 500 pl of 0.01 M phosphate buffer (pH 7.0) containing 0.5% BSA at 37°C for 10 min and then were washed twice with the fresh buffer by centrifugation (10,000 x g, 5 min). The resulting pellets were resuspended in the fresh buffer, and then the labeled toxin (1.8 pmol) was added. The mixture was incubated at 37°C for 10 min. After pellets were washed twice by centrifugation (10,000 x g, 5 min), the radioactivity of the pellets was counted.
Each point is the mean value of 9 or 10 determinations. The standard errors are shown by vertical lines. Binding of 1251-epsilon-toxin to the membrane fractions was expressed as a percentage of the binding of the labeled toxin under control conditions. Symbols: *, P < 0.01 compared with control; **, P < 0.001 compared with control; *, TNBS-inactivated toxin; V, SA-inactivated toxin; *, EDCinactivated toxin; 0, NAI-inactivated toxin; [1, toxin; A, NBS-inactivated toxin; A, prototoxin.
epsilon-prototoxin specifically inhibited biological activities of epsilon-toxin and accumulation of the labeled toxin in mouse brain (14) . It therefore appears that epsilon-toxin specifically binds to and then acts on the brain.
The labeling of epsilon-toxin was performed through the conjugation of amino groups in the toxin with iodinated ester by the Bolton-Hunter method (1) . We have reported that modification of free amino groups in epsilon-toxin by TNBS and SA caused significant loss of the biological activities of the toxin (19) but did not have a significant effect on the binding of the toxin to the receptors (15) . It therefore seemed reasonable to examine the binding of epsilon-toxin to the membrane fractions prepared from rat brain by using 12511 epsilon-toxin.
We examined the binding properties of epsilon-toxin to rat brain homogenates and membrane fractions. The data showed that there was a single class of binding site with high affinity in the brain (Kd, 2.5 nM) and in the membranes (Kd, 3.3 nM) and that there were a small number of sites in the brain (Bm.,~9 .0 pmol of toxin bound per mg of protein) and in the synaptosomal membranes (Bmax, 25.5 pmol of toxin bound per mg of protein), suggesting that the specific binding site may be located in the synaptosomes. Treatment of the membrane fractions with trypsin and phospholipase C resulted in no effect on binding. On P-Bungarotoxin was reported to inhibit the evoked release of acetylcholine from the terminals of motor neurons (10) . Botulinum toxin inhibits the evoked release of the transmitter from cholinergic nerve terminals (24) . Furthermore, it has been reported that these toxins exhibit binding to synaptosomes from rat brain (16, 25) . In the present work, epsilon-toxin was found to bind specifically to the membrane fractions from rat brain. P-Bungarotoxin inhibited the binding of the labeled epsilon-toxin. Botulinum toxin had no effect on epsilon-toxin binding. However, the binding site of P-bungarotoxin is reported to be different from that of botulinum toxin (16) . The binding site of epsilon-toxin seems specific for epsilon-toxin in the sense that competition binding was observed with the presynaptically acting protein 1-bungarotoxin but not with botulinum toxin. 
